EF
MRK icon

Empowered Funds’s Merck MRK Stock Holding History

Empowered Funds’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.1M Sell
507,815
-178,382
-26% -$20.6M 0.39% 29
2025
Q4 		$72.2M Buy
686,197
+83,405
+14% +$7.83M 1.23% 9
2025
Q3 		$50.6M Buy
602,792
+129,923
+27% +$10.7M 0.51% 18
2025
Q2 		$37.4M Sell
472,869
-28,033
-6% -$2.23M 0.42% 26
2025
Q1 		$45M Buy
500,902
+180,118
+56% +$16.8M 0.64% 14
2024
Q4 		$31.9M Buy
320,784
+72,387
+29% +$7.46M 0.47% 21
2024
Q3 		$28.2M Buy
248,397
+147,267
+146% +$17.5M 0.44% 25
2024
Q2 		$12.5M Sell
101,130
-85,570
-46% -$11M 0.22% 90
2024
Q1 		$24.6M Buy
186,700
+102,841
+123% +$12.7M 0.44% 30
2023
Q4 		$9.14M Buy
83,859
+15,569
+23% +$1.62M 0.23% 84
2023
Q3 		$7.03M Buy
68,290
+1,381
+2% +$149K 0.21% 96
2023
Q2 		$7.72M Sell
66,909
-224
-0.3% -$25.4K 0.27% 56
2023
Q1 		$7.14M Buy
+67,133
New +$7.25M 0.42% 49
2022
Q4 		– Sell
-3,428
Closed -$350K – 533
2022
Q3 		$295K Buy
+3,428
New +$306K 0.03% 295

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Empowered Funds's MRK Position: Q1 2026 in Review

Empowered Funds reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $20.6M and leaving 507,815 shares worth $61.1M. The position accounts for 0.39% of the portfolio, ranked #29.

Empowered Funds first reported a position in MRK in Q3 2022 and has held it in 14 quarters since. The position peaked at $72.2M in Q4 2025. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Empowered Funds held 507,815 shares of Merck worth $61.1M as of Q1 2026.
  • Empowered Funds sold 178,382 Merck shares in Q1 2026, an estimated $20.6M.
  • Merck made up 0.39% of Empowered Funds's portfolio in Q1 2026, its #29 holding.
  • Empowered Funds first reported a position in Merck in Q3 2022 and has held it in 14 quarters since.
  • Empowered Funds's Merck position peaked at $72.2M in Q4 2025.
  • 3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.